Found: 25
Select item for more details and to access through your institution.
Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry.
- Published in:
- 2015
- By:
- Publication type:
- Correction Notice
Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127045
- By:
- Publication type:
- Article
SMA CARNI-VAL TRIAL PART II: A Prospective, Single- Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0021296
- By:
- Publication type:
- Article
SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012140
- By:
- Publication type:
- Article
Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005268
- By:
- Publication type:
- Article
Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcome measures in a cohort of ambulatory adults with spinal muscular atrophy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical trial of L-Carnitine and valproic acid in spinal muscular atrophy type I.
- Published in:
- 2018
- By:
- Publication type:
- journal article
SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
SMA valiant trial: A prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy.
- Published in:
- Muscle & Nerve, 2014, v. 49, n. 2, p. 187, doi. 10.1002/mus.23904
- By:
- Publication type:
- Article
Reliability of the modified hammersmith functional motor scale in young children with spinal muscular atrophy.
- Published in:
- Muscle & Nerve, 2011, v. 44, n. 2, p. 246, doi. 10.1002/mus.22040
- By:
- Publication type:
- Article
Compound muscle action potential and motor function in children with spinal muscular atrophy.
- Published in:
- Muscle & Nerve, 2010, v. 42, n. 5, p. 703, doi. 10.1002/mus.21838
- By:
- Publication type:
- Article
Homocysteine Levels Are Associated with Increased Risk of Congestive Heart Failure in Patients with and without Coronary Artery Disease.
- Published in:
- Cardiology, 2007, v. 107, n. 3, p. 178, doi. 10.1159/000095344
- By:
- Publication type:
- Article
C-Reactive Protein Predicts Death in Patients with Non-Ischemic Cardiomyopathy.
- Published in:
- Cardiology, 2005, v. 104, n. 4, p. 196, doi. 10.1159/000088138
- By:
- Publication type:
- Article
Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?
- Published in:
- Cardiology, 2004, v. 101, n. 4, p. 185, doi. 10.1159/000076695
- By:
- Publication type:
- Article
Sodium Channel Mutations and Susceptibility to Heart Failure and Atrial Fibrillation.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 4, p. 447, doi. 10.1001/jama.293.4.447
- By:
- Publication type:
- Article
Erratum to: Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 531, doi. 10.3233/JND-221531
- By:
- Publication type:
- Article
Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2.
- Published in:
- PLoS ONE, 2024, v. 19, n. 10, p. 1, doi. 10.1371/journal.pone.0309666
- By:
- Publication type:
- Article
Natural history of infantile-onset spinal muscular atrophy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function.
- Published in:
- Annals of Neurology, 2005, v. 57, n. 5, p. 704
- By:
- Publication type:
- Article
Perspectives on Clinical Trials in Spinal Muscular Atrophy.
- Published in:
- Journal of Child Neurology, 2007, v. 22, n. 8, p. 957, doi. 10.1177/0883073807305665
- By:
- Publication type:
- Article
Baseline results of the Neuro NEXT spinal muscular atrophy infant biomarker study.
- Published in:
- Annals of Clinical & Translational Neurology, 2016, v. 3, n. 2, p. 132, doi. 10.1002/acn3.283
- By:
- Publication type:
- Article
Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article